Abstract
The central nervous system is truly remarkable in its ability to maintain stable normal function amidst myriad environmental factors which tend to disrupt its equilibrium. It maintains its functional balance by means of adaptive mechanisms. During the normal course of existence external forces act on the organism, altering its internal environment so that important elements fall outside their range of optimal functioning. Exceeding the optimal range activates specialized adaptive mechanisms which tend to restore the internal environment to the optimal state. Thus, the initial change acts as a stimulus to processes which tend to reverse that change. This regulatory pattern of action and reaction is ineffective only when the initial change is so extreme as to be irreversible or when the mechanisms to counter the initial change are either weakened or absent.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ansell, G. B., Beeson, M. F., Bradley, P. B., 1969, The effects of stressful, stimuli and drugs of the concentrations and turnover rates of monoamine in rat brain, in: The Present Status of Psychotropic Drugs, pp. 299–301, Proc. CINP VI Intern. Congr. ( Tarragone, 1968 ).
Barbeau, A., Murphy, C. F. and Sourkes, T. L., 1961, Excretion of dopamine in diseases of basal ganglia. Science 133: 1706.
Barbeau, A., Tétreault, L., Oliva, L., Morazain, L., and Gardin, L., 1966, Pharmacology of akinesia. Investigations on 3,4-dimethoxy-phenylethylamine, Nature (London) 209: 719.
Bechtereva, N. P., 1971, The Neurophysiological Base of the Mental Activity in Man,Leningrad.
Bechtereva, N. P., Grigorovitch, K. A., and Zontov, V. V., 1963, On the pathogenesis and the therapy of the Raynaud disease, Zh. Nevropatol. i Psikhiatr. 5: 641.
Bechtereva, N. P., Bondartchuk, A. N., and Zontov, V. V., 1965, The Raynaud’s Disease,Leningrad.
Bechtereva, N. P., Bondartchuk, A. N., and Smirnov, V. M., Trochatchev A. I., 1967, The Physiology and the Pathophysiology of the Deep Brain Structures in Man,Leningrad-Moskva.
Bechtereva, N. P., Kambarova, D. K., and Matveev, Yu.K., 1970, The functional characteristic of the links of the cerebral control systems for mental and motor functions in man, Fiziol. Zh. SSSR 56: 1081.
Bertler, A., 1964, Dopamine in the central nervous system, in: Biochemical and Neurophysiological Correlations of Centrally Acting Drugs ( E. Trabucchi, R. Paoletti, and N. Canal. eds.), pp. 51–55, Pergamon Press, New York.
Carlsson, A., 1959, The occurrence, distribution and physiological role of catecholamines in the nervous system, Pharmacol. Rev. 11: 490.
Carlsson, A., 1972, Biochemical and pharmacological aspects of parkinsonism, Acta Neurologica Scand. 48: 11.
Connor, J. D., 1970, Caudate nucleus neurones: correlation of the effects of substantia nigra stimulation with iontophoretic dopamine, J. Physiol. 208 (3): 323.
Ehringer, H., and Hornykiewicz, O., 1960, Verteilung von Noradrenalin und Dopamin (3Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems, Klin. Wochschr. 38: 1236.
Everett, G. M., Borcherding, J. W., 1970, L-dopa: effect on concentrations of dopamine, nor-epinephrine, and serotonin in brains of mice, Science 168: 84Q
Fanchaps, A., Daepfner, N., Weidmann, H., and Cerletti, A., 1960, Pharmakologische Charakterizierung von Deseril, einem Serotonin-Antagonisten, Schweiz. Med. Wochschr. 90: 1040.
Feltz, P., 1970, Relation nigrostriatale: essai de différenciation des excitatins et inhibitions par micro-iontophorèse de dopamine, J. Physiol. Suppl. 62 (1): 151.
Freedman, D. X., 1961, Effect of LSD-25 on brain serotonin, J. Pharmacol. Exptl. Therap. 134: 160.
Friedhoff, A. J., Hekimian, L., Alpert, M., and Tobach, E., 1963, DIhydroxyphenylalanine in extrapyramidial diseases, J. Am. Med. Assoc. 184: 285.
Friedhoff, A. J., Hekimian, L., Alpert, M., and Tobach, E., 1963, DIhydroxyphenylalanine in extrapyramidial diseases, J. Am. Med. Assoc. 184: 285.
Friedhoff, A. J., Hekimian, L., Alpert, M., and Tobach, E., 1963, DIhydroxyphenylalanine in extrapyramidial diseases, J. Am. Med. Assoc. 184: 285.
Granerus, Ann-Katherine, Jagenburg, Rudolf, Stig, Rödjer and Alvar, Svanborg, 1971, Inhibition of L-phenylalanine absorption by L-dopa in patients with parkinsonism, Proc. Soc. Exptl. Biol. Med. 137, 3: 942.
Hornykiewicz, 0., 1964, The role of dopamine (3-hydroxytyramine) in parkinsonism, in: Biochemical and Neurophysiological Correlations of Centrally Acting Drugs, ( E. Trabucchi, R. Paoletti and N. Canal, eds.), pp. 57–68, Pergamon Press, New York.
Hornykiewicz, 0., 1966, Dopamine (3-hydroxytyramine) and brain function, Pharmacol. Rev. 18: 925.
Hull, C. D., Bernardi, G., and Buchwald, N. A., 1970, Intracellular responses of caudate neurons to brain stem stimulation, Brain Res. 22: 163.
Iliukhina, V. A., 1972, The slow electrical processes in the human brain during mental and motor activity (with regard to the conditions of the central biochemical mediation), A vtoref. Kand. Diss., Leningrad.
Kambarova, D. K., 1967, The central mechanisms of the paroxysmal diseases of non-epileptic kind. Avtoref. Kand. Diss., Leningrad.
Kaminsky, L. S., 1959, Processing of the Clinical and Laboratory Data,Moskva. Kaminsky, L. S., 1964, Statistical Processing of the Clinical and Laboratory Data,Moskva.
Kostowski, W., and Giacalone, E., 1969, Stimulation of various forebrain structures and brain 5HT, 5HIAA and behaviour in rats, in: The Present Status of Psychotropic Drugs, pp. 289–291 Proc. CINP. VI. Intern. Cong. ( Tarragone, 1968 ).
Kostowski, W., and Giacalone, E., 1969, Stimulation of various forebrain structures and brain 5HT, 5HIAA and behaviour in rats, in: The Present Status of Psychotropic Drugs, pp. 289–291 Proc. CINP. VI. Intern. Cong. ( Tarragone, 1968 ).
Matlina, E. Sh., and Menshikov, V. V., 1967, The Clinical Biochemistry of the Catecholamines, pp. 113–127, Moskva.
Misyuk, N. S., Prigun, P. P., Korenevskaia, A. A., and Misyuk, E. M., 1965, The Data on the Serotonin Metabolism Under Inhibitory Condition of Brain, Minsk.
Smirnov, V. M., 1967, In: The Localization Problems in Psychoneurology, Vol. X, pp. 22–48, ( Tr. in-st im. Bechtereva ), Leningrad.
Udenfriend, S., Titus, E., and Weissbach, H., 1955, The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay, J. Biol. Chem. 216: 499.
Verzeano, M., 1972, Pacemakers, synchronization and epilepsy, in: Synchronization of EEG Activity in Epilepsies ( H. Petsche and M. A. B. Brazier, eds.), pp. 155–188, Springer-Verlag, Wien, New York.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Bechtereva, N.P., Kambarova, D.K., Pozdeev, V.K. (1975). Functional Interrelationships of Principal Catecholaminergic Centers in the Brain. In: Friedhoff, A.J. (eds) Catecholamines and Behavior · 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3135-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3135-3_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3137-7
Online ISBN: 978-1-4684-3135-3
eBook Packages: Springer Book Archive